Synovo's main pharmacology activities are based on assays and models for the selection of drug candidates with improved properties of Absorbtion, Disposition, Metabolism and Elimination (ADME or DMPK). Synovo establishes these parameters using human derived cells, proteins and systems wherever feasible to ensure the relevance of its data to use in man.
Synovo is engaged in projects in the fields of anti-inflammatory and immune suppressive drug optimisation on behalf of clients from the pharmaceutical industry. Synovo is also working in partnership with public sector laboratories to improve its systems and extend its technologies to protein and nucleic acid drugs.
Based in Tübingen, home of one of the best known Universities in Germany, Synovo GmbH benefits from access to cutting edge technology, highly skilled staf Click for details>>
Germany
